Newsroom
Kyowa Hakko Kirin Announces Results from US Phase 1/2 Clinical Trial of KW-0761 (Anti-CCR4 Humanized Monoclonal Antibody) in Patients with Cutaneous T-cell Lymphoma
Wed, 12/08/2010
Click here to read more on Kyowa Hakko Kirin Announcement from US Phase 1/2 Clinical Trial results of Anti-CCR4 Humanized Monoclonal Antibody.